Back to results
US 2020/0262844 A1Published application
Rock kinase inhibitors
AssigneeCervello Therapeutics, LLC.
InventorsMatthew Randolph Lee, Anthony Joseph Varano, JR., Thomas P. Bobinski
Life of this patent
Estimating the term…
Abstract
The present invention relates to compounds that inhibit ROCK activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of inhibiting ROCK activity and methods for treating, for example cerebral cavernous malformation syndrome (CCM) and cardiovascular diseases using the compounds and pharmaceutical compositions of the present invention.
Claims13
A compound is selected from the group consisting of:
- and pharmaceutically acceptable salts thereof.
Dependencies are inferred from the claim text.